Infectious uveitis in Virginia

Figures & data

Table 1 Infectious uveitis diagnosis distribution by age (years)

Diagnosis	Age group (years)				Total	P-value
	0–19	20–39	40–59	≥60
Toxoplasma	0	2	4	8	14	0.014*
Fungal endophthalmitis	0	1	0	2	3	0.564
Tuberculosis	0	0	0	1	1	0.317
Syphilis	0	0	0	1	1	0.317
Fungal sclerokeratitis s/p PK	0	0	0	1	1	0.317
Herpetic anterior uveitis (HSV)	2	5	7	6	20	0.796
Herpetic anterior uveitis (HZO)	0	2	6	9	17	0.017*
Acute retinal necrosis (CMV)	0	0	2	2	4	0.564
Acute retinal necrosis**	1	1	1	4	7	0.127
Acute retinal necrosis (VZV)	0	0	0	3	3	0.020*
Herpetic panuveitis (HZO)	0	0	0	1	1	0.317
CMV retinitis	1	2	2	0	5	0.437
Total	4	13	22	38	77

Notes:

* Statistically significant at 5% level.

** No virus isolated.

Abbreviations: PK, penetrating keratoplasty; HSV, herpes simplex virus; HZO, herpes zoster ophthalmicus; CMV, cytomegalovirus; VZV, varicella-zoster virus.

Table 2 Visual acuity at the final follow-up by diagnosis

Diagnosis	≥20/40 No (%)	20/50–20/200 No (%)	<20/200 No (%)	Total no of patients	P-value
Toxoplasma	10 (71.4)	2 (14.3)	2 (14.3)	14	0.006*
Fungal endophthalmitis	0 (0)	0 (0)	3 (100)	3	0.540
Tuberculosis	1 (100)	0 (0)	0 (0)	1	0.724
Syphilis	1 (100)	0 (0)	0 (0)	1	0.724
Fungal sclerokeratitis s/p PK	0 (0)	0 (0)	1 (100)	1	0.479
Herpetic anterior uveitis (HSV)	7 (35.0)	9 (45.0)	4 (20.0)	20	0.874
Herpetic anterior uveitis (HZO)	15 (88.2)	1 (5.9)	1 (5.9)	17	<0.001*
Acute retinal necrosis (CMV)	1 (25.0)	1 (25.0)	2 (50.0)	4	0.504
Acute retinal necrosis**	1 (14.3)	2 (28.6)	4 (57.1)	7	0.504
Acute retinal necrosis (VZV)	1 (33.3)	0 (0)	2 (66.7)	3	0.724
Herpetic panuveitis (HZO)	0 (0)	0 (0)	1 (100)	1	0.480
CMV retinitis	2 (40.0)	1 (20.0)	2 (40.0)	5	0.752
Total	39 (50.6)	16 (20.8)	22 (28.6)	77

Notes:

* Statistically significant at 5% level.

** No virus isolated.

Abbreviations: PK, penetrating keratoplasty; HSV, herpes simplex virus; HZO, herpes zoster ophthalmicus; CMV, cytomegalovirus; VZV, varicella-zoster virus.